Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes.
Sujuan DingSheng XuYong MaGang LiuHongmei JangJun FangPublished in: Biomolecules (2019)
The inflammasome is a multiprotein complex that acts to enhance inflammatory responses by promoting the production and secretion of key cytokines. The best-known inflammasome is the NLRP3 (nucleotide-binding oligomerization domain-like receptor [NLR] family pyrin domain-containing 3) inflammasome. The evidence has shown that the NLRP3 inflammasome, IL-1β, thioredoxin-interacting protein (TXNIP), and pyroptosis play vital roles in the development of diabetes. This review summarizes the regulation of type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) by NLRP3 via modulation of glucose tolerance, insulin resistance, inflammation, and apoptosis mediated by endoplasmic reticulum stress in adipose tissue. Moreover, NLRP3 participates in intestinal homeostasis and inflammatory conditions, and NLRP3-deficient mice experience intestinal lesions. The diversity of an individual's gut microbiome and the resultant microbial metabolites determines the extent of their involvement in the physiological and pathological mechanisms within the gut. As such, further study of the interaction between the NLRP3 inflammasome and the complex intestinal environment in disease development is warranted to discover novel therapies for the treatment of diabetes.
Keyphrases
- nlrp inflammasome
- glycemic control
- endoplasmic reticulum stress
- type diabetes
- insulin resistance
- adipose tissue
- oxidative stress
- cardiovascular disease
- induced apoptosis
- high fat diet
- metabolic syndrome
- microbial community
- weight loss
- skeletal muscle
- binding protein
- cell proliferation
- polycystic ovary syndrome
- small molecule
- signaling pathway
- pi k akt
- high fat diet induced